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Abstract
Background: Methoxyacetic acid (MAA) is the active metabolite of the widely used industrial chemical ethylene glycol 
monomethyl ether, which is associated with various developmental and reproductive toxicities, including neural 
toxicity, blood and immune disorders, limb degeneration and testicular toxicity. Testicular toxicity is caused by 
degeneration of germ cells in association with changes in gene expression in both germ cells and Sertoli cells of the 
testis. This study investigates the impact of MAA on gene expression in testicular Leydig cells, which play a critical role 
in germ cell survival and male reproductive function.
Methods: Cultured mouse TM3 Leydig cells were treated with MAA for 3, 8, and 24 h and changes in gene expression 
were monitored by genome-wide transcriptional profiling.
Results: A total of 3,912 MAA-responsive genes were identified. Ingenuity Pathway analysis identified reproductive 
system disease, inflammatory disease and connective tissue disorder as the top biological functions affected by MAA. 
The MAA-responsive genes were classified into 1,366 early responders, 1,387 mid-responders, and 1,138 late 
responders, based on the time required for MAA to elicit a response. Analysis of enriched functional clusters for each 
subgroup identified 106 MAA early response genes involved in transcription regulation, including 32 genes associated 
with developmental processes. 60 DNA-binding proteins responded to MAA rapidly but transiently, and may 
contribute to the downstream effects of MAA seen for many mid and late response genes. Genes within the 
phosphatidylinositol/phospholipase C/calcium signaling pathway, whose activity is required for potentiation of 
nuclear receptor signaling by MAA, were also enriched in the set of early MAA response genes. In contrast, many of the 
genes responding to MAA at later time points encode membrane proteins that contribute to cell adhesion and 
membrane signaling.
Conclusions: These findings on the progressive changes in gene expression induced by MAA in a cultured Leydig cell 
model may help elucidate signaling pathways that lead to the testicular pathophysiological responses induced by 
MAA exposure and may identify useful biomarkers of MAA toxicity.
Background
Methoxyacetic acid (MAA) is the primary active metabo-
lite of the industrial chemical ethylene glycol monom-
ethyl ether, a component of paints, inks, varnishes and
anti-icing additive in jet fuels [1]. MAA exposure is asso-
ciated with various developmental and reproductive tox-
icities in both rodents and humans, including decreased
sperm production reflecting increased apoptosis of pri-
mary spermatocytes [2] and is accompanied by gene
expression changes in germ cells (reviewed in [3]). How-
ever, the precise testicular cell target(s) of MAA that lead
to the observed increase in germ cell apoptosis are uncer-
tain. The survival and proper functioning of germ cells
requires cooperation of several testicular cell types,
including Sertoli cells, which nurture the developing
germ cells through spermatogenesis [4], and Leydig cells,
the major site of testosterone production in males [5].
MAA-induced changes in gene expression in Sertoli and
Leydig cells could therefore have a significant impact on
germ cell behavior and overall reproductive function.
While MAA-induced changes in Sertoli cell gene expres-
sion have been described [6], the impact of MAA on Ley-
dig cell gene expression has not been investigated.
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Environmental chemicals that interfere with normal
Leydig cell gene expression have the potential to impact
germ cell function. Leydig cell lines have been useful for
investigating the testicular actions of environmental
chemicals, including effects on gene expression [7], and
in the case of MAA, changes in gene expression have
been investigated using the cultured TM3 Leydig cell
model, which is derived from the testis of the immature
Balb/c mouse [8]. In particular, MAA was found to alter
the expression of TM3 cell genes involved in testosterone
biosynthesis (Cyp17a1) and androgen binding (Shbg) [9].
Presently, we use this same Leydig cell model to charac-
terize the sequential changes in gene expression that
occur following MAA exposure. Genome-wide transcrip-
tional profiling was carried out to elucidate the global
impact of MAA treatment at each of three time points (3,
8 and 24 h) in an effort to identify both early (primary)
and late (secondary) MAA response genes. Cells were
treated with MAA at 5 mM, corresponding to the plasma
concentration associated with ethylene glycol monom-
ethyl ether-induced germ cell toxicity in mice [10], and at
1 mM, to identify genes affected at a concentration of
MAA similar to that seen in exposed humans [11]. A total
of 3,912 genes responsive to 5 mM MAA treatment were
identified, 1,629 of which were also responsive at 1 mM
MAA. The early MAA-responsive genes include 106
genes involved in transcriptional regulation, whereas
m a n y  o f  t h e  g e n e s  r e s p o n d i n g  t o  M A A  a t  l a t e r  t i m e
points encode membrane proteins that contribute to cell
adhesion and membrane signaling. These MAA-induced
perturbations of cellular and biological functions may
help elucidate the signaling pathways perturbed by this
environmental toxicant and explain its mechanism of
action at the gene level.
Methods
Chemicals and reagents
MAA and horse serum were purchased from Sigma
Chemical Co. (St. Louis, MO). DMEM-F12 culture
medium, fetal bovine serum (FBS) and TRIzol reagent
were purchased from Invitrogen Corp. (Carlsbad, CA).
MAA treatment of TM3 cells and RNA analysis
Mouse TM3 Leydig cells (American Type Culture Collec-
tion, Manassas, VA) were grown in DMEM-F12 medium
containing 5% horse serum and 2.5% FBS. Cells were
grown to ~60% confluence and treated with culture
medium alone, or with culture medium containing 1 mM
or 5 mM MAA for either 3, 8 or 24 h. Total RNA was then
isolated using TRIzol reagent, followed by incubation
with RQ1 RNAse-free DNAse for 1 h at 37°C and then
heat inactivation at 75°C for 5 min. A total of 6 cultures of
TM3 cells were independently treated with MAA under
each of the 6 treatment conditions specified above (i.e., 1
mM or 5 mM MAA for either 3, 8 or 24 h), and the corre-
sponding 36 RNA samples were validated by RNA integ-
rity analysis (Agilent Bioanalyzer). Each RNA sample was
also validated in terms of the MAA response by qPCR
analysis using SYBR Green I-based chemistry [12] and
primers specific for 3 genes known to respond to MAA
(Cyp17a1, Shbg, and Igfbp3; [9]) to verify consistency of
the MAA responses. Dissociation curves were examined
after each qPCR run to ensure amplification of a single,
specific product at the correct melting temperature. The
6 RNA samples for each treatment condition were then
used to prepare two independent pools (n = 3 RNA sam-
ples each) for microarray analysis with dye swaps, as
described below. Microarray results were validated for 6
genes, three of which were induced at both 1 mM and 5
mM MAA, and three of which were repressed at 5 mM
MAA. Data are presented as the expression of the gene of
interest relative to an 18 S RNA internal control in the
MAA-treated sample compared with the untreated con-
trol, as determined using the comparative Ct method
[13], and are based on duplicate RNA samples for each of
three independent experiments for each condition of
MAA treatment, with all six samples assayed in triplicate
(mean ± SE for n = 3).
Microarray analysis
The Agilent Whole Genome Mouse Microarray platform
(catalog G4122F; Agilent Technology) was used to char-
acterize MAA-induced changes in TM3 cell gene expres-
sion. This array contains 41,174 mouse probes (features),
each consisting of a 60-mer oligonucleotide. Accession
numbers were obtained for 39,355 out of the 41,174
probes, of which 33,011 were assigned gene names. An
additional 3,570 probes were assigned gene names using
the microarray probe annotation tool AILUN [14] to map
microarray probes to Entrez genes [15]. Each probe cor-
responding to a distinct mouse transcript is referred to as
representing a separate gene/gene product. RNA samples
pooled from 3 separate TM3 cell cultures were analyzed
in a total of six separate competitive hybridization experi-
ments, corresponding to the above specified combina-
tions of exposure time (3 h, 8 h, and 24 h) and MAA
concentration (1 mM, 5 mM). Sample labeling, hybridiza-
tion to microarrays, scanning and calculation of normal-
ized expression ratios were carried out at the Wayne State
University Institute of Environmental Health Sciences
microarray facility using Alexa 555 and Alexa 647 amino-
allyl-aRNA samples as described [16]. Dye swap experi-
ments were carried out using a separate pool of three
MAA-treated TM3 cultures. To carry out the dye swaps,
Alexa 555-labeled RNA from one of the MAA-treatment
conditions was mixed with Alexa 647-labeled RNA from
the untreated control at the same time point, and vice
versa. TIFF images of each scanned slide were analyzedBagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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using Agilent's feature extraction software with linear and
LOWESS normalization followed by combination of dye-
swap samples and calculation of weighted ratios and p-
values based on the Rosetta error model using Rosetta
Resolver (version 5.1, Rosetta Biosoftware, Seattle, WA)
[17]. Features flagged in either channel were excluded
from analysis. The final set of expression ratios and p-val-
ues is available as GEO series GSE-20625.
Statistical analysis
In those cases where two or more probes mapped to the
same gene accession and gave the same pattern of expres-
sion across all microarrays (reflecting probe redundancy
in the array platform), a single representative probe was
retained in the final data set. Of the 41,174 probes
included on the array, 33,940 non-redundant probes were
identified for the 5 mM MAA treatment data set. The sta-
tistical significance of differential expression of each cor-
responding transcript was determined by application of a
filter (p < 0.005) to the Rosetta-generated p-values. Next,
an absolute log2 ratio filter of >2 SD above the mean value
was combined with the above p-value filter to determine
the number of gene transcripts that were differentially
regulated at any of the three time points. In total, 3,912
probes met the combined thresholds for differential
expression in at least one of the three 5 mM MAA time
points. Of the 33,940 non-redundant probes, 5,031 met
the >2 SD differential expression filter for at least one of
the three microarray comparisons. The number of probes
expected to meet the combined threshold (p < 0.005 and
>2 SD fold-change expression) by chance is 0.005 × 5,031,
or 25 probes. The actual number of probes meeting the
combined threshold was 3,912, corresponding to an
apparent FDR of 25/3,912, or 0.64%. Commonly used
multiple testing correction methods such as Bonferroni
or Holm step-down were not applied as these eliminate a
large number of true positives and introduce an inappro-
priate over correction.
A system of binary and decimal flags was used to clus-
ter the differentially regulated genes into subgroups
based on expression ratios [18]. Briefly, all genes that met
both the fold change and the statistical significance
threshold criteria (average ratio >2, and p < 0.005) for one
or more of the three 5 mM MAA treatment conditions
were assigned a binary flag value of 1, 2, 4 respectively.
The sum of these binary flag values defines the whole
number portion of the flag assigned to each gene and
indicates which of the three microarrays met the speci-
fied threshold criteria in our analysis. In addition, deci-
mal values of 0.1, 0.01, 0.001 or 0.2, 0.02, 0.002, were
respectively assigned to each of the three microarrays to
indicate the direction of regulation of the genes in the
array (decimal flags with values of 1 indicate up-regula-
tion, whereas those with a value of 2 indicate down-regu-
lation). Thus, for each gene, the Total Flag Sum (TFS),
comprising the binary sum plus the decimal values, indi-
cates which of the three arrays met the threshold criteria
for inclusion and the direction of regulation. A similar
flag system was used to identify common response genes
at 1 mM and 5 mM, with by extending the TFS to six
binary flags (1, 2, 4, 8, 16 and 32) and six decimal values
(0.1, 0.01, 0.001, 0.0001, 0.00001, 0.000001 or 0.2, 0.02,
0.002, 0.0002,0.00002, 0.000002), except that in that case
the average ratio threshold was set at >2SD, correspond-
ing to a fold change of >2-fold for the 5 mM MAA data
set and >1.5-fold for the 1 mM MAA data set.
Principal component analysis was used to extract char-
acteristic patterns from the six microarray data sets. 5624
genes responding to either 1 mM MAA or 5 mM MAA
were se lected based on the combined criteria of |fold-
change| >2 SD from mean and p < 0.005 at one or more
time points. The data were then pre-processed by loga-
rithm 2 transformation of the expression ratio for each
gene and by normalizing each gene's ratio to a mean value
of zero and to a SD of 1 across the set of 6 arrays. Matrix
A, which represents the gene expression data under all 6
microarray conditions, was decomposed by the singular
value decomposition: A = U￿VT, where both U (an N × M
matrix) and V (an M × M matrix) are orthogonal matri-
ces, and ￿ (an M × M matrix) is diagonal. The loading
matrix V consists of the weights of individual genes in the
principal components. VT is the transpose of V. We
denote X = U￿, where the principal component scores are
specified.
Motif enrichment analysis
Flexmodule_motif, a de novo motif discovery function
based on Gibbs motif sampler implemented in CisGe-
nome [19], was used to identify DNA motifs overrepre-
sented within 1 kb upstream of the transcription start
sites of sets of genes either up or down regulated by
MAA. The DNA motifs that best matched those overrep-
resented motifs were identified using STAMP, a database
for alignment and similarity search for DNA motifs [20].
Next, Fisher's exact test was applied to test whether these
known motifs are enriched in genes of each group com-
pared to control gene sets. Two sets of genes were used as
background controls: 1) genes expressed at a modest or
high level in untreated TM3 cells (microarray signal
intensity > 200) that were not responsive to MAA treat-
ment (|expression fold-change| < 1.2 following 5 mM
MAA treatment at 3, 8 and 24 h); and 2) genes expressed
in TM3 cells at a low to undetectable level (microarray
signal intensity <50) and |expression fold-change| <1.2 at
all three time points following MAA treatment.Bagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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Ingenuity Pathway Analysis, GO enrichment and heat maps
The list of MAA-regulated genes was analyzed using
Ingenuity Pathway Analysis software (Ingenuity Systems,
Mountain View, CA) based on gene ontology, biological
processes, molecular function, and genetic networks.
This software maps the biological relationship of
uploaded genes into networks based on published litera-
ture for each gene. The biological function network, for
example, identifies biological functions and diseases that
are most significant to the data set. Genes that met the
threshold criteria for MAA responsiveness and were
associated with biological functions or diseases in the
Ingenuity Pathway knowledge base were considered for
further analysis. Fischer's exact test was used to calculate
a p-value to determine the probability that each biological
function/disease assigned to the data set is due to chance
alone. A relevancy score was assigned to each network in
the data set to estimate the relevancy of the network to
the gene list uploaded. A higher relevancy score means
that the network is more relevant to the gene list entered.
Top pathways in each network are listed according to
their  p-values. Classified gene lists were analyzed for
enrichment of Gene Ontology functional annotation
clusters using DAVID, a web accessible bioinformatics
database [21,22]. Heat maps were drawn using Java
Treeview [23].
Results
Overall impact of MAA on TM3 cell gene expression
The impact of MAA treatment on mouse TM3 cell gene
expression was determined in cells treated with either 1
mM or 5 mM MAA for 3, 8 or 24 h. These concentrations
of MAA were chosen based on earlier reports demon-
strating similar MAA concentrations in plasma of
rodents exposed to toxic doses of ethylene glycol
monomethyl ether [10] and in urine of humans exposed
to ethylene glycol monomethyl ether in occupational situ-
ations [11]. Under these conditions, MAA did not cause
any loss of TM3 cell viability over the course of at least 48
hr. The three time points were selected to distinguish
early MAA response genes (putative direct targets, whose
expression does not require de novo protein synthesis)
from late response genes (secondary response genes)
[24]. RNA samples representing each time point were
analyzed on expression microarrays in direct comparison
to vehicle-treated controls.
Principal component analysis was applied to evaluate
the expression patterns in the six microarrays. The first
two of 6 principal components account for more than
70% of the variance in the overall data set (Fig. 1A). The
pattern of the first component represents genes showing
a steady increase in expression, or a steady decrease in
expression, at both MAA concentrations (Fig. 1B), while
the second component represents genes that show small
c h a n g e s  i n  e x p r e s s i o n  a s  a  f u n c t i o n  o f  t i m e  a t  1  m M
MAA as compared to 5 mM MAA (Fig. 1B and Addi-
tional file 1). Based on these analyses, 37% of the variance
in the data can be explained by the treatment duration,
while 34% of the variance is due to different responses at
low vs. high MAA concentrations. Most of the genes that
show a different response at each MAA concentration
show a more significant response to 5 mM MAA than 1
mM MAA, as would be expected (Fig. 2 and Additional
file 1). To explore the genes and pathways that may
potentially contribute to MAA toxicity, we focused our
analysis on the effect of 5 mM MAA, and describe below
common pathways triggered by both 1 mM and 5 mM
MAA.
Figure 1 Principal component analysis of six microarray data 
sets. Plots of relative variance (A) and the coefficients of first and sec-
ond components (B) are shown. Each coefficient indicates the weight 
of a particular treatment in the principal component. The first principal 
component represents a measure of expression change over time. The 
second coefficient captures information about the expression pattern 
affected by MAA dosage.Bagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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3,912 of the 41,174 microarray probes met the thresh-
old criteria (absolute log 2 ratio >2 SD above the mean
and p < 0.005), corresponding to an apparent false discov-
ery rate (FDR) of 0.64%, for at least one of the three 5 mM
MAA time points after elimination of redundant probes.
The levels of 1,382, 2,122 and 2,226 transcripts were sig-
nificantly altered by MAA at 3 h, 8 h and 24 h, respec-
tively. A complete list of the MAA-responsive genes
together with their expression ratios and fluorescence
signal intensities at each time point is provided in Addi-
tional file 2. Ingenuity Pathway Analysis was used to map
the biological relationship of the MAA-responsive genes
into networks constructed based on published literature
about each gene (Table 1). Gene networks that responded
to MAA include reproductive system development and
function, embryonic development and tissue morphol-
o g y .  D i s e a s e  c a t e g o r i e s  t h a t  w e r e  i m p a c t e d  b y  M A A
include reproductive system disease, inflammatory dis-
ease, inflammatory response, connective tissue disorders
and skeletal and muscular disorders. The biological func-
tions affected by MAA include cellular movement, cell-
to-cell signaling and interaction, cellular development
and cell death (Table 1).
Clustering and functional analysis by significance and 
differential expression
The impact of MAA treatment was further investigated
by classification of the 3,912 MAA-responsive genes
using a binary flagging system termed Total Flag Sum
(TFS) [18], whereby each gene is categorized based upon
its expression ratio and p-value in each of the three
microarray experiments. Genes that responded to MAA
rapidly, i.e., by the 3 h MAA time point, were distin-
guished from the mid-response genes (response by 8 h)
and the late responders (response by 24 h) (Table 2 and
Additional file 2). A total of 1,366 early response genes
were identified, which were further categorized based on
the persistence of their response to MAA (Table 2 and
Fig. 2A). Among the early response genes, 642 genes
responded at the 3 h time point but not at 8 h (early tran-
sient response genes), with 377 transcripts induced and
265 transcripts repressed. 106 of these early transient
genes participate in transcriptional regulation, as deter-
Figure 2 Heat map for MAA response genes. Shown are the expression profiles of early (A), mid (B) and late (C) MAA response genes based on log 
2 ratios. The numbers of transcripts in each subgroup is marked in parenthesis.Bagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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mined by gene functional annotation analysis using
DAVID [21,22] (Table 3 and Additional file 3), and could
contribute to the complex changes in the transcriptome
associated with MAA treatment. Indeed, 102 of the 1,366
early response genes encode DNA-binding proteins, 60 of
which showed a transient response to MAA (Additional
file 4). Interestingly, 32 of these 102 early response DNA-
binding proteins have been linked to developmental pro-
cesses by DAVID analysis (Fig. 3). Moreover, 31 of the 102
genes contain zinc finger domains (Additional file 4).
Functions have not been determined for many of these
genes; however, two of the induced zinc-finger protein
genes,  Egr1  and Egr2, are notable insofar as Egr1-Egr4
double-mutant male mice are characterized by physiolog-
ically low serum testosterone levels and atrophy of andro-
gen-dependent organs due to the loss of luteinizing
hormone production in the pituitary gland [25]. More-
over, Egr1 is a key transcription factor implicated in the
development and progression of prostate cancer [26].
Early response genes whose expression was altered by
MAA at 3 h and 8 h, but not at 24 h, were designated
early sustained up or early sustained down genes (Table 2
and Additional file 2; TFS groups 3.110 and 3.220, respec-
tively). These genes are enriched in several cancer-related
functional clusters, including insulin-like growth factor
binding (Htra3, Igfbp5, Cyr61, Wisp1), GTP binding
(Tubb6, Tgtp, Rnd1, Gbp1, Rab40b, Gbp2, Rhobtb1,
Rabl3, Gbp3), cytokine activity (Clcf1, Kitl, Socs2, Cxcl5,
Tnfsf11, Cxcl1, Cx3cl1, Il12a) and negative regulation of
apoptosis (Cln8, Clcf1, Nuak2, Kitl, Dlx1, Notch1, Bcl2,
Table 1: Top biological functions and networks affected by MAA
Name p-value range No. molecules
A. Top Biological Functions: Diseases and Disorders
Reproductive System Disease 3.45E-10 - 4.68E-04 160
Inflammatory Disease 1.76E-09 - 1.23E-03 507
Inflammatory Response 1.18E-08 - 1.77E-03 279
Connective Tissue Disorders 5.10E-07 - 1.23E-03 44
Skeletal and Muscular Disorders 5.10E-07 - 1.23E-03 516
B. Molecular and Cellular Functions
Cellular Movement 7.17E-12 - 1.81E-03 327
Cell-To-Cell Signaling and Interaction 3.03E-11 - 1.53E-03 333
Cellular Growth and Proliferation 3.74E-10 - 1.75E-03 492
Cellular Development 7.76E-08 - 1.81E-03 455
Cell Death 8.78E-07 - 1.69E-03 490
C. Physiological System Development and Function
Tissue Development 3.47E-10 - 1.53E-03 353
Cardiovascular System Development & Function 5.55E-08 - 1.56E-03 169
Organismal Development 5.55E-08 - 1.36E-03 240
Hematological System Development & Function 7.98E-08 - 1.75E-03 348
Immune Cell Trafficking 1.58E-07 - 1.77E-03 206
D. Associated Network Functions (top five gene network functions)
1. Reproductive System Development and Function, Embryonic Development, Tissue Morphology.
2. Infection Mechanism, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities.
3. Carbohydrate Metabolism, Small Molecule Biochemistry, Molecular Transport.
4. Behavior, Nervous System Development and Function, Gene Expression.
5. Cardiovascular System Development and Function, Embryonic Development, Tissue Development.
Shown is a summary of results of Ingenuity Pathway bio-functional analysis to identify biological functions or disease networks that are most 
significant to the 5 mM MAA data set. Genes that met the threshold criteria defined in Materials and Methods and were associated with 
biological functions or diseases in the Ingenuity Pathway Analysis Knowledge Base were considered in the analysis. Each network includes a 
set of molecules, which usually perform more than one function. Fischer's exact test was used to calculate a p-value indicating the probability 
that each biological function and/or disease assigned to the data set is due to chance alone. Shown is the p-value range, which indicates the 
lowest and highest p-values corresponding to all molecules included in each network, and the total number of molecules present in the 
network.Bagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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Serpinb9, Clec2 d, Nr4a1, Fastkd2, Rassf5, Elmo1) (see
Additional file 3 for complete listing of genes). Corre-
sponding KEGG pathways include cytokine and receptor
interaction, TLR-Jak-STAT signaling pathway, and phos-
phatidylinositol signaling. Other early genes whose
response to MAA was maintained at 8 h and 24 h were
designated early persistent genes (Table 3 and Additional
file 2; TFS groups 3.111 and 3.222); examples include
genes implicated in cytokine receptor interaction and cal-
cium signaling (Additional files 3 and 5).
1,387 mid-response genes responded to MAA at 8 h,
while 1,138 late-response genes did not respond to MAA
until 24 h (Figs. 2B, C and Table 2). These secondary
response genes are enriched in a variety of signaling path-
ways and functional clusters, such as macromolecule
metabolic process (Atf3, Adra1b, Fbxl16, Frk, Gls,
Nanos1, Pcyt1b), cell adhesion (Arhgap6, Col1a2, Col6a2,
Kitl, Tek, Thbs1, Tsc1), interferon-activated genes
(Ifi202b, Ifi203, Ifi204, Ifi205), genes active in the extra-
cellular space (Acp5, Csf1r, Muc2, Nppb, Ramp3), T cell
activation and differentiation (Cd74, H2-DMa, Il15, Il7,
Itgal) and metabolism of xenobiotics by cytochrome P450
and other enzymes (see Additional file 3 for complete list-
ing of genes).
DNA motifs associated with TM3 cell transcriptional 
responses
CisGenome [19] was used to discover de novo motifs
overrepresented in the sets of genes up or down regulated
genes by MAA at each time point. GC rich motifs were
found to be over represented in the proximal promoters
of MAA up regulated genes. Motif comparison against
the TRANSFAC database [27] revealed that these GC
rich motifs are most similar to two known motifs, SP1
and KROX, which correspond to the binding sites for
transcription factors of the SP1 and EGR families, respec-
tively. Both motifs are enriched in MAA-regulated genes
compared to a background gene set comprised of TM3
cell non-expressed genes, with enrichment scores ranging
up to 2.1 (Additional file 6). However, motif enrichment
was not observed when using as background a set of TM3
cell expressed genes that did not respond to MAA (Addi-
tional file 6). Thus, while SP1 and KROX/EGR motifs are
overrepresented in some MAA-induced genes, these
motifs also characterize TM3 cell expressed genes more
generally.
Impact of MAA on genes associated with testicular function
MAA had a wide range of effects on gene products
important for testosterone biosynthesis, spermatogene-
sis, and testicular development and function (Fig. 4 and
Additional file 7). For example, sex hormone binding
globulin (Shbg) was up regulated by 5 mM MAA at all 3
time points, while the induction of Cyp11a1, Rhox5 (Pem)
and Hoxb13 and the repression of Insl3 were seen at the
24 h MAA time point.
Common response genes and pathways activated at low 
MAA concentration
Early, mid and late MAA response genes were also identi-
fied in the 1 mM MAA-treated TM3 cells. Early response
genes common to the 1 mM and 5 mM MAA treatments
(482 genes; Additional file 8) are expected to be enriched
in direct targets of MAA; 294 of these genes were induced
and 188 were repressed by MAA. DAVID analysis
showed that phosphatidylinositol/phospholipase C/cal-
cium signaling and cytokine/cytokine receptor interac-
tions were the most significantly enriched pathways for
the common early gene set. Pathways enriched in the
common mid and late response genes include cell adhe-
sion and focal adhesion (Additional file 9).
Real time qPCR validation
To confirm the results of the microarrays, qPCR analysis
was performed for three genes that were induced
(Rasgrp2,  Itpka  and  Kcnab328;  Fig. 5A) and for three
genes that were repressed by MAA at all three time
points (Pcdhb15, Abca9 and Ly96; Fig. 5B). Rasgrp2 and
Itpka were of particular interest since our earlier studies
had shown that MAA induces the Map kinase pathway
and the PI3 kinase pathway in tsA201 cells [9]. Fig. 5
shows that the overall trends of expression seen by qPCR
were consistent with the microarray data, although the
fold-changes did not always match those of the microar-
ray data, as is commonly seen.
Discussion
MAA is the active metabolite of the industrial chemical
ethylene glycol monomethyl ether, a widely studied tes-
ticular toxicant. Presently, we characterize changes in
gene expression induced by MAA in the cultured testicu-
lar Leydig cell model TM3. This investigation, carried out
as a time course of MAA exposure, was designed to gain
further insight into the range of changes in gene expres-
sion that MAA induces, including gene responses that
could contribute to the testicular toxicity that is a hall-
mark of MAA exposure. The TM3 cell line was chosen
based on our earlier finding that these cells are responsive
to MAA, which induces changes in the expression of sev-
eral genes related to androgen synthesis and activity [9].
MAA did not cause any changes in TM3 cell viability over
the course of at least 48 hr; nevertheless, we observed
extensive changes in TM3 cell gene expression. 3,912
genes were altered in their expression by 5 mM MAA, the
plasma MAA concentration associated with germ cell
toxicity in mice [10]; 1,168 of these genes responded inBagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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Page 8 of 14
common to 1 mM MAA, which is more relevant to the
exposure level seen in humans [11]. As discussed below,
the gene expression changes and associated cellular path-
ways impacted by MAA in this cellular model parallel
some of the toxicities associated with MAA exposure,
suggesting that these findings in TM3 cells may serve as a
model for MAA-induced toxicities in other cell types as
well.
Rapid MAA induction of zinc finger transcription factors
Analysis of the time dependence of MAA-induced gene
responses allowed us to identify genes that respond to
MAA rapidly (within 3 h), as well as genes whose altered
in expression persists and could potentially serve as bio-
markers of MAA exposure. Environmental chemical-
induced toxicities are often associated with early gene
responses [28]; therefore, genes that respond to MAA
rapidly may provide insights into the pathophysiological
changes caused by MAA. Presently, we found that 102 of
the 1,366 early response genes encode DNA-binding pro-
teins, 32 of which have been linked to developmental pro-
cesses (Fig. 3). Interestingly, 60 of the early response
DNA-binding proteins showed a transient response to
MAA, i.e., gene induction responses seen at 3 h were
largely reversed by 8 h (Additional file 4), suggesting a
feedback loop for the regulation of transcriptional activ-
ity by MAA. For example, ATF1 (activating transcription
factor 1), a bZIP domain containing protein belonging to
the CREB family, was down regulated 2-fold after 3 h of
MAA treatment, while CREB5 (cAMP response element-
binding 5), another CREB family transcription factor, was
up regulated 3.7-fold. Upon activation, CREB binds as a
dimer to the cAMP response element (CRE), where it
promotes the recruitment of the transcriptional coactiva-
tors CREB binding protein (CBP) and p300 [29]. The
impact of this opposite regulation of these two CREB
family proteins by MAA on the expression of CRE-regu-
lated genes is unknown. One CRE-regulated gene, Egr1,
was induced 4.5-fold after 3 h MAA exposure. EGR1 is a
zinc-finger transcription factor that binds to a GC-rich
motif, as do several other zinc finger proteins, which may
activate or repress their targets by acting in combination
[30]. Previously, evolutionarily conserved zinc finger
transcription factor binding sites recognized by WT1,
EGR1, SP1, SP2, AP2 and GATA1 were identified in the
promoters of 24 differentially expressed prostate cancer
genes from eight mammalian species [26], suggesting
these zinc finger proteins play a pivotal role in the pros-
tate. Here, both EGR1 and SP1 binding sites were found
to be overrepresented in TM3 Leydig cell-expressed
genes compared to TM3 cell non-expressed genes. Fur-
ther studies, including gene knock-down and in vivo tran-
scription factor binding assays, are needed to clarify
whether these putative sites are true EGR1/SP1 binding
sites, whether they are functional, and what impact their
binding may have on TM3 cell gene activation or repres-
sion.
Table 2: Classification of MAA responsive genes by duration of MAA treatment required to elicit response
Group Sub-group 3 h MAA 8 h MAA 24 h MAA Genes in each subgroup (number)
Early (1366 genes) early transient up Up - - 351
early transient up Up - Up 26
early sustained up Up Up - 149
early persistent up Up Up Up 223
early transient down Down - - 245
early transient down Down - Down 20
early sustained down Down Down - 198
early persistent down Down Down Down 154
Mid (1387 genes) mid transient up - Up - 344
mid sustained up - Up Up 466
mid transient down - Down - 395
mid sustained down - Down Down 182
Late (1138 genes) l a t e  u p --U p 7 7 5
late down - - Down 363
The 5 mM MAA-responsive genes were divided into 3 groups, early response (3 h), mid response (8 h) and late response (24 h) based on the 
minimum period of MAA exposure that was required to evoke a gene response compared to control cells. The direction of response is indicated 
as Up (up-regulation), Down (down-regulation) or - (no significant response). 21 other genes that did not meet these MAA response criteria are 
shown in Additional file 2.Bagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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Table 3: Gene functional clusters affected by MAA for each sub-group
Response Top term Enrich-ment score Cluster gene count p-value
Early transient GO:0045449, Regulation of transcription 5.96 106 3.23E-07
GO:0044424, Intracellular part 5.8 211 1.11E-06
GO:0065007, Biological regulation 5.54 124 6.15E-07
Early sustained GO:0050794, Regulation of cellular process 3.41 66 1.85E-04
IPR000867: Insulin-like growth factor-binding protein, IGFBP 3.04 4 6.28E-04
Domain: von Willebrand factor, type C 2.91 4 4.81E-04
Early persistent GO:0048731, System development 2.19 48 1.19E-03
GO:0048514, Blood vessel morphogenesis 2.13 9 2.17E-03
GO:0044421, Extracellular region part 2.07 43 6.46E-03
Mid transient GO:0007155, Cell adhesion 3.11 34 3.28E-04
GO:0044237, Cellular metabolic process 2.25 347 1.60E-04
IPR004021: HIN-200/IF120x 2.13 5 9.10E-04
Mid sustained GO:0044421, Extracellular region part 8.22 109 7.30E-10
IPR015493: Protocadherin beta 6.56 15 1.68E-12
IPR003128: Villin headpiece 4.39 5 2.85E-05
Late GO:0044421, Extracellular region part 10.34 165 5.60E-12
GO:0048856, Anatomical structure development 4.4 144 1.10E-05
GO:0044449, Contractile fiber part 3.47 12 1.75E-04
Listed are the top three gene functional clusters affected by MAA as determined using DAVID database. The top term for each cluster, the cluster 
enrichment score and the number of regulated genes in each cluster are listed.
Impact of MAA on protein kinase pathways
Protein kinases play a significant role in MAA-induced
toxicity, and protein kinase inhibitors can minimize these
effects [31]. Of the 3,912 MAA-regulated genes identified
in our study, 91 code for protein kinases, as determined
by Ingenuity Pathway Analysis (Additional file 11). These
kinases are associated with amino acid metabolism, post-
translational modification, small molecule biochemistry,
cell death and cell movement. The top canonical path-
ways affected include inositol metabolism, axonal guid-
ance signaling, FAK signaling, germ cell-Sertoli cell
junction signaling, and nicotinate and nicotinamide
metabolism. MAA can act as a hormone sensitizer to
enhance the transcriptional activity of several nuclear
receptors without itself being a hormone mimetic,
although the underlying mechanism is only partly under-
stood [9,32]. Our previous studies demonstrated that the
potentiation of androgen receptor activity by MAA
requires tyrosine kinase signaling that is independent of
the RAS-MEK-ERK signaling pathway but requires PI3
kinase activity [9]. Consistently, in this study, we
observed that the phosphoinositide/phospholipase C/cal-
c i u m  p a t h w a y  i s  e n r i c h e d  i n  t h e  s e t  o f  e a r l y  r e s p o n s e
genes in common to both 1 mM and 5 mM MAA treat-
ment. Several key factors in this pathway are induced by
MAA, including phospholipases C, PI3 kinases, and IP3
receptor (Additional file 9). Both the ERK and PI3 kinase
pathways have been suggested to be responsible for Egr1
up regulation [33,34]. Further studies will be required to
identify the underlying molecular mechanism whereby
MAA activates these signaling pathways leading to induc-
tion of Egr1 and its downstream targets.
Effect of MAA treatment on histone genes
Several genes encoding histone proteins were induced by
MAA treatment. Thus, Hist1h1d, Hist1h4k, and
Hist2h2aa1 were early MAA response genes, Hist1h1c,
Hist2h2be, and Hist3h2ba were mid-response genes, and
9 other Hist genes, including 6 encoding histone 1 pro-
teins, were late response genes (Additional file 2). H1 his-
tones stabilize compact, higher order structures ofBagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
http://www.rbej.com/content/8/1/65
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chromatin, regulate gene expression, and participate in
chromatin-based processes like DNA replication and
repair [35]. The altered expression of this linker histone
in MAA-treated cells could destabilize chromatin archi-
tecture and contribute to malignant transformation or
genetic disorders. Hist1h1d is significantly up regulated
in rat testis within 4 h of MAA treatment, and this change
has been correlated with increased acetylation of core
histones [36]. The induction of mouse Hist1h1d seen in
our study is consistent with that earlier report, and sup-
ports the utility of the mouse TM3 model for identifying
gene changes that may be linked to MAA toxicity. It will
be interesting to determine the relationship between his-
tone up regulation and the other gene expression changes
caused by MAA.
Biological pathways affected by MAA
Many of the prominent toxicological effects of MAA or
the parent toxicant, ethylene glycol monomethyl ether,
are well characterized [37] and several studies have eluci-
dated effects of MAA on intracellular signaling pathways
and changes in gene expression [3,36]. Using Ingenuity
Pathway Analysis we identified pathways related to repro-
ductive system development and function, embryonic
development and tissue morphology to be the most
affected by MAA. Moreover, at all three time points
examined, MAA affected genes associated with several
disease pathways, reproductive system disease, inflam-
matory disease, connective tissue disorders and skeletal
and muscular disorders. Alteration of these pathways in
the corresponding target tissues could contribute to some
of the physiological diseases and disorders that have been
associated with MAA exposure, including MAA-induced
disruption of neurogenesis and limb and digit differentia-
tion in mice [1], hematopoiesis [38], cell death [39] and
immune system disorders [40-42]. MAA also induced sig-
nificant changes in the expression of membrane proteins,
which is reflected in the dysregulation of genes involved
in cell-to-cell signaling, cell adhesion and cell mobility as
indicated by Ingenuity Pathway functional analysis (Table
1). Indeed, a majority of the genes that were induced or
repressed by MAA under all treatment conditions belong
to this category (Table 3 and Additional file 3). Moreover,
32 of 102 early MAA response genes encoding DNA-
Figure 3 32 DNA-binding early MAA response genes that are as-
sociated with developmental processes. Each column represents a 
GO term associated with development process; genes (indicated by 
rows) with specific GO terms are marked with green.
Figure 4 Heat map presenting the effects of MAA treatment for 3, 
8 and 24 hr on genes related to testicular function. Shown is the hi-
erarchical clustering heat map for 35 testis-associated genes based on 
log 2 ratios (scale is as shown at the bottom).Bagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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binding proteins are associated with developmental pro-
cesses (Fig. 3).
Genes related to testicular function whose expression
was significantly altered by MAA include Cyp11a1,
Hsd17b11, Shbg and Insl3 and Rhox5 (Fig. 4 and Addi-
tional file 7), which encode proteins involved in testoster-
one biosynthesis or development of the male
reproductive system. Changes in the expression of these
genes might impact testosterone biosynthesis/availability
and influence spermatocyte survival. CYP11A1 cleaves
the side chain of cholesterol to yield pregnenolone, the
initial step in the pathway leading from cholesterol to ste-
roid hormone production [43]. HSD17B11 is a hydroxys-
teroid dehydrogenase that is required for synthesis of
androstenedione, a precursor of testosterone [44]. Insu-
lin-like 3 (INSL3; Leydig insulin-like peptide) is impor-
tant in testis descent [45], with male mice mutant for
Insl3  exhibiting cryptorchidism or defects in testis
Figure 5 qPCR analysis of select genes. Shown are qPCR data for three genes induced at all three time points by both 1 mM and 5 mM MAA (panel 
A; Rasgrp2, Itpka and Kcnab328) and three genes repressed by 5 mM MAA at all three time points (panel B; Pcdhb15, Abca9 and Ly96). qPCR primers 
used for this analysis are shown in Additional file 10.Bagchi et al. Reproductive Biology and Endocrinology 2010, 8:65
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descent due to abnormal gubernaculum development
[46]. Steroid hormone binding globulin (SHBG) binds
androgens and its over-expression can cause testosterone
depletion and toxicity [47,48]. The expression of
Cyp17a1, which catalyzes the 17-hydroxylase and lyase
activities required for testosterone synthesis [49], was
increased in MAA-treated cells, as determined by qPCR,
although this change was not seen in the microarray anal-
ysis. Further studies are required to determine if these
changes affect Leydig cell testosterone production, which
could have a direct impact on germ cell survival and tox-
icity. MAA also induced two homeobox genes, Rhox5 and
Hoxb13, which have been implicated in the modulation of
a n d r og e n  r ec e p t o r - r e gu la t ed  g e n e  e x p r e s s i o n  i n  Se rt o l i
cells and in prostate, respectively [50,51]. Rhox5, which is
considered a Sertoli cell marker gene but is also expressed
at a low level in Leydig cells in vivo [52], is thus an MAA-
responsive transcription factor that may mediate some of
the effects of MAA on downstream targets [50]. Finally,
MAA down regulated estrogen receptor-α, suggesting the
MAA can also impact estrogenic signaling in testicular
cells. Of note, MAA also disrupts estrogenic signaling in
MCF7 cells in vitro and in the mouse uterus in vivo [53].
Metabolic labeling studies establish that MAA can be
activated to the thioester 2-methoxyacetyl- coenzyme A,
which enters the tri-carboxylic acid cycle [1]. Conceiv-
ably, just as acetyl coenzyme A is funneled into multiple
metabolic pathways, 2-methoxyacetyl-coenzyme A may
enter multiple pathways, including tri-carboxylic acid
cycle, fatty acid metabolism and amino acid metabolism
with affects on cellular metabolism and gene expression.
Acetyl coenzyme A is also essential for histone acetyla-
tion, a key event in gene transcription [54], suggesting
that 2-methoxyacetyl-coenzyme A could also affect that
process. We observed significant MAA-induced changes
in expression of genes involved in cellular metabolism,
oxidation status, transcription and gene expression, as
might be caused by a metabolite which can enter and
impact several key cellular metabolic and regulatory
pathways. Further studies using inhibitors and metabo-
lites of specific pathways are needed to test these hypoth-
eses.
Conclusions
In this study, we monitored the progressive changes in
gene expression induced by MAA in a cultured Leydig
cell model and detected extensive changes in TM3 cell
gene expression. The MAA-responsive pathways identi-
fied are linked to reproductive system development and
function, embryonic development and tissue morphol-
ogy. These MAA-induced perturbations of cellular and
biological functions may help elucidate the testicular
pathophysiological responses induced by MAA exposure
and identify useful biomarkers of MAA toxicity.
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